Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine J Mummery

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 28, 2021
Current directions in tau research: Highlights from Tau 2020Claire Sexton, Heather Snyder, Dirk Beher, et al.
Brain Communications|August 16, 2021
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromesRoss W Paterson, Laura A Benjamin, Puja R Mehta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2025
Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global ConferenceBess Frost, James B Rowe, Rufus O Akinyemi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2026
The landscape of dementia research, diagnosis, treatment, and care in Latin AmericaClaudia K Suemoto, Nilton Custodio, Diego Aguilar, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 23, 2025
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathologyEric M McDade, Nicolas R Barthélemy, Guoqiao Wang, et al.
JAMA Neurology|April 29, 2024
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical TrialOlivia Wagemann, Haiyan Liu, Guoqiao Wang, et al.
Annals of Neurology|September 24, 2022
Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer DiseaseNelly Joseph-Mathurin, Jorge J Llibre-Guerra, Yan Li, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 28, 2021
Current directions in tau research: Highlights from Tau 2020Claire Sexton, Heather Snyder, Dirk Beher, et al.
Brain Communications|August 16, 2021
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromesRoss W Paterson, Laura A Benjamin, Puja R Mehta, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 29, 2025
Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global ConferenceBess Frost, James B Rowe, Rufus O Akinyemi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2026
The landscape of dementia research, diagnosis, treatment, and care in Latin AmericaClaudia K Suemoto, Nilton Custodio, Diego Aguilar, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 23, 2025
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathologyEric M McDade, Nicolas R Barthélemy, Guoqiao Wang, et al.
JAMA Neurology|April 29, 2024
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical TrialOlivia Wagemann, Haiyan Liu, Guoqiao Wang, et al.
Annals of Neurology|September 24, 2022
Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer DiseaseNelly Joseph-Mathurin, Jorge J Llibre-Guerra, Yan Li, et al.
Pageof 8